Clinical implications of plasma homocysteine measurement in cardiovascular disease

被引：42

作者：

Still, RA ^{[1
]}

McDowell, IFW ^{[1
]}

机构：

[1] Univ Wales Hosp, Dept Biochem Med, Cardiff CF4 4XW, S Glam, Wales

来源：

关键词：

D O I：

10.1136/jcp.51.3.183

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

[No abstract available]

引用

页码：183 / 188

页数：6

共 27 条

[1] Putative mechanisms for vascular damage by homocysteine
Bellamy, MF
McDowell, IFW
[J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (02) : 307 - 315
[2] BOSTOM AG, 1995, CLIN CHEM, V41, P948
[3] A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES
BOUSHEY, CJ
BERESFORD, SAA
OMENN, GS
MOTULSKY, AG
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13): : 1049 - 1057
[4] Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
denHeijer, M
Koster, T
Blom, HJ
Bos, GMJ
Briet, E
Reitsma, PH
Vandenbroucke, JP
Rosendaal, FR
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) : 759 - 762
[5] Dudman NPB, 1996, CLIN CHEM, V42, P2028
[6] Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease
Duell, PB
Malinow, MR
[J]. CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (01) : 28 - 34
[7] EVTOVSKI J, 1995, CLIN CHEM, V41, P757
[8] FISKERSTRAND T, 1993, CLIN CHEM, V39, P263
[9] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE
FROSST, P
BLOM, HJ
MILOS, R
GOYETTE, P
SHEPPARD, CA
MATTHEWS, RG
BOERS, GJH
DENHEIJER, M
KLUIJTMANS, LAJ
VANDENHEUVEL, LP
ROZEN, R
[J]. NATURE GENETICS, 1995, 10 (01) : 111 - 113
[10] Garg UC, 1997, CLIN CHEM, V43, P141